Precigen Inc (PGEN)
US$ 1.35-1.46%
Price Chart
Key Statistics
Market Cap
$ 504.76M
P/E Ratio
0.00
Revenue (TTM)
$ 4.2M
Volume
1.82M
52W High
$ 2.17
52W Low
$ 0.65
Dividend Yield
0.00%
Beta
1.78
Technicals
50-Day MA
1.5516
200-Day MA
1.3381
52 Week High
2.17
52 Week Low
0.6513
About PGEN
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorder.
Employees
143
Headquarters
Germantown, MD
CEO
Mr. Randal J. Kirk J.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg